Monthly Archives: January 2017

FEDERAL CURES ACT CALLS FOR ADVANCES IN CLINICAL TRIAL MANAGEMENT

In December 2016, Former President Obama signed the 21st Century Cures Act. Two years in the making, this landmark, bipartisan bill seeks to drive advancement of the American healthcare system. Costing $6.3 billion dollars, the Cures Act will: Accelerate the approval of new drugs and medical devices Reinvest in Vice President Biden’s Cancer Moonshot, aimed at… Read more »






Sampleminded Poised to Aid Clinical Trial Sponsors with Compliance of New Data Sharing Rules

The clinical trial rules are changing, and the question is, how will researchers, laboratories and drug companies meet the requirements? Beginning January 18, 2017, researchers will need to meet tighter parameters regarding the reporting of clinical trials data according to new policies and regulations released by the National Institutes of Health and U.S. Health and… Read more »